These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 27565680)
1. Transcriptional Regulation of Human Cytosolic Sulfotransferase 1C3 by Peroxisome Proliferator-Activated Receptor γ in LS180 Human Colorectal Adenocarcinoma Cells. Dubaisi S; Fang H; Kocarek TA; Runge-Morris M Mol Pharmacol; 2016 Nov; 90(5):562-569. PubMed ID: 27565680 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional Regulation of Cytosolic Sulfotransferase 1C2 by Vitamin D Receptor in LS180 Human Colorectal Adenocarcinoma Cells. Barrett KG; Fang H; Kocarek TA; Runge-Morris M Drug Metab Dispos; 2016 Aug; 44(8):1431-4. PubMed ID: 27130351 [TBL] [Abstract][Full Text] [Related]
3. Regulation of human cytosolic sulfotransferases 1C2 and 1C3 by nuclear signaling pathways in LS180 colorectal adenocarcinoma cells. Rondini EA; Fang H; Runge-Morris M; Kocarek TA Drug Metab Dispos; 2014 Mar; 42(3):361-8. PubMed ID: 24335393 [TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels. Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106 [TBL] [Abstract][Full Text] [Related]
5. Expression of the orphan cytosolic sulfotransferase SULT1C3 in human intestine: characterization of the transcript variant and implications for function. Duniec-Dmuchowski Z; Rondini EA; Tibbs ZE; Falany CN; Runge-Morris M; Kocarek TA Drug Metab Dispos; 2014 Mar; 42(3):352-60. PubMed ID: 24335392 [TBL] [Abstract][Full Text] [Related]
6. Switching subtype-selectivity: Fragment replacement strategy affords novel class of peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists. Shioi R; Okazaki S; Noguchi-Yachide T; Ishikawa M; Makishima M; Hashimoto Y; Yamaguchi T Bioorg Med Chem Lett; 2017 Jul; 27(14):3131-3134. PubMed ID: 28539218 [TBL] [Abstract][Full Text] [Related]
7. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate. Takacs ML; Abbott BD Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030 [TBL] [Abstract][Full Text] [Related]
8. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer. Park EY; Cho IJ; Kim SG Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131 [TBL] [Abstract][Full Text] [Related]
9. The human semaphorin 6B gene is down regulated by PPARs. Collet P; Domenjoud L; Devignes MD; Murad H; Schohn H; Dauça M Genomics; 2004 Jun; 83(6):1141-50. PubMed ID: 15177567 [TBL] [Abstract][Full Text] [Related]
10. Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor. Fang HL; Strom SC; Cai H; Falany CN; Kocarek TA; Runge-Morris M Mol Pharmacol; 2005 Apr; 67(4):1257-67. PubMed ID: 15635043 [TBL] [Abstract][Full Text] [Related]
11. Human mannose-binding lectin 2 is directly regulated by peroxisome proliferator-activated receptors via a peroxisome proliferator responsive element. Tachibana K; Takeuchi K; Inada H; Sugimoto K; Ishimoto K; Yamashita M; Maegawa T; Yamasaki D; Osada S; Tanaka T; Rakugi H; Hamakubo T; Sakai J; Kodama T; Doi T J Biochem; 2013 Sep; 154(3):265-73. PubMed ID: 23711995 [TBL] [Abstract][Full Text] [Related]
12. Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells. Röhrl C; Kaindl U; Koneczny I; Hudec X; Baron DM; König JS; Marian B J Cancer Res Clin Oncol; 2011 Jan; 137(1):29-39. PubMed ID: 20221637 [TBL] [Abstract][Full Text] [Related]
13. Three peroxisome proliferator-activated receptor isotypes from each of two species of marine fish. Leaver MJ; Boukouvala E; Antonopoulou E; Diez A; Favre-Krey L; Ezaz MT; Bautista JM; Tocher DR; Krey G Endocrinology; 2005 Jul; 146(7):3150-62. PubMed ID: 15790725 [TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A. Olsen H; Haldosén LA Exp Cell Res; 2006 May; 312(8):1371-80. PubMed ID: 16457814 [TBL] [Abstract][Full Text] [Related]
15. In vivo imaging reveals selective PPAR activity in the skin of peroxisome proliferator-activated receptor responsive element-luciferase reporter mice. El-Jamal N; Dubuquoy L; Auwerx J; Bertin B; Desreumaux P Exp Dermatol; 2013 Feb; 22(2):137-40. PubMed ID: 23362873 [TBL] [Abstract][Full Text] [Related]
16. Citrate carrier promoter is target of peroxisome proliferator-activated receptor alpha and gamma in hepatocytes and adipocytes. Damiano F; Gnoni GV; Siculella L Int J Biochem Cell Biol; 2012 Apr; 44(4):659-68. PubMed ID: 22249025 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present). Takada I; Makishima M Expert Opin Ther Pat; 2020 Jan; 30(1):1-13. PubMed ID: 31825687 [No Abstract] [Full Text] [Related]
18. An intact DNA-binding domain is not required for peroxisome proliferator-activated receptor gamma (PPARgamma) binding and activation on some PPAR response elements. Temple KA; Cohen RN; Wondisford SR; Yu C; Deplewski D; Wondisford FE J Biol Chem; 2005 Feb; 280(5):3529-40. PubMed ID: 15572375 [TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptors-α and -γ, and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissue. Rosell M; Hondares E; Iwamoto S; Gonzalez FJ; Wabitsch M; Staels B; Olmos Y; Monsalve M; Giralt M; Iglesias R; Villarroya F Endocrinology; 2012 Mar; 153(3):1162-73. PubMed ID: 22253419 [TBL] [Abstract][Full Text] [Related]
20. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism. Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]